Abstract

Bilateral renal cell carcinoma (RCC) is a rare disease that can be classified as either familial or sporadic. Studying the cellular molecular characteristics of sporadic bilateral RCC is important to provide guidance for clinical treatment. Cellular molecular characteristics can be expressed at the RNA level, especially at the single-cell degree. Single-cell RNA sequencing (scRNA-seq) was performed on bilateral clear cell RCC (ccRCC). A total of 3,575 and 3,568 high-quality single-cell transcriptome data were captured from the left and right tumour tissues, respectively. Gene characteristics were identified by comparing left and right tumours at the scRNA level. The complex cellular environment of bilateral ccRCC was presented by using scRNA-seq. Single-cell transcriptomic analysis revealed high similarity in gene expression among most of the cell types of bilateral RCCs but significant differences in gene expression among different site tumour cells. Additionally, the potential biological function of different tumour cell types was determined by gene ontology (GO) analysis. The transcriptome characteristics of tumour tissues in different locations at the single-cell transcriptome level were revealed through the scRNA-seq of bilateral sporadic ccRCC. This work provides new insights into the diagnosis and treatment of bilateral RCC.

Highlights

  • Renal cell carcinoma (RCC) is a common tumour in the urinary system with lower incidence rate compared with bladder and prostate cancers [1]

  • A total of 3,568 and 3,575 high quality single-cells were obtained in ccRCC1 and ccRCC2, respectively, after Quality Control (QC) by Seurat [21, 22] (Table 2)

  • Unbiased clustering classified the cells in ccRCC1 into 15 different types from cluster 1 to cluster 15, namely, CD8+ T cells, CD4+ T cells, tumour associated macrophages (TAMs), NK cells, NK-T cells, cancer-associated fibroblast (CAF), tumour cells, CD14+ monocytes, endothelial cells 1, FCGR3A+ monocytes, B cells, exhausted T cells, mast cells, endothelial cells 2 and proliferative CD8+ T cells (Figure 3A)

Read more

Summary

Introduction

Renal cell carcinoma (RCC) is a common tumour in the urinary system with lower incidence rate compared with bladder and prostate cancers [1]. Most RCC cases have a better prognosis than other cancers in the urinary system, such as upper urinary tract urothelial carcinoma and muscular infiltrating bladder carcinoma [1, 3]. This rate has been increasing in the past decades [4, 5]. The incidence rates of bilateral RCC are not high, studying this disease will help understand its progress and prognosis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call